General
Preferred name
Withaferin A
Synonyms
NSC-101088 ()
NSC 273757 ()
NSC-273757 ()
P&D ID
PD019347
CAS
5119-48-2
Tags
available
natural product
drug candidate
Drug Status
investigational
Max Phase
1.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Withaferin A is a steroidal lactone isolated from Withania somnifera, inhibits NF-kB activation and targets vimentin, with potent antiinflammatory and anticancer activities. Withaferin A is an inhibitor of endothelial protein C receptor (EPCR) shedding.
PRICE
397
DESCRIPTION
Withaferin A was the first withanolide class phytochemical to be isolated (from Withania somnifera, a.k.a. winter cherry or ashwagandha) . More than 300 withanolides have subsequently been isolated from other plant species, and many pharmacological actions have been associated with them.
(GtoPdb)
DESCRIPTION
WITHAFERIN A is a novel class of NFkappaB inhibitors, which hold promise as novel anti-inflammatory agents for treatment of various inflammatory disorders and/or cancer.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
24
Organisms
0
Compound Sets
8
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
37
Molecular Weight
470.27
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
6
Aromatic Ring Count
0
cLogP
3.35
TPSA
96.36
Fraction CSP3
0.79
Chiral centers
11.0
Largest ring
6.0
QED
0.49
Structural alerts
1
Nonspecific/NOS
Nuisance compounds
Custom attributes
(extracted from source data)
Pathway
NF-¦ÊB
Apoptosis
Target
Ferroptosis
NF-κB
NF-??
Source data

